某院2014-2016年阿片类镇痛药使用分析

发布时间：2018-04-15 22:26

本文选题：阿片类镇痛药 + 销售金额　；参考：《中国药房》2017年23期

【摘要】：目的:了解阿片类镇痛药在某院的使用情况,为促进临床合理用药提供参考。方法:对该院2014-2016年阿片类镇痛药的销售金额、用药频度(DDDs)、日均费用(DDC)和排序比(B/A)等进行回顾性分析与比较。结果:该院阿片类镇痛药的年销售金额在2015年略有增长,在2016年则出现了明显的下降;芬太尼透皮贴剂(8.4 mg)、氨酚羟考酮片和注射用盐酸瑞芬太尼的DDDs一直稳居前3位,枸橼酸芬太尼注射液(0.1 mg)和硫酸吗啡缓释片的DDDs呈逐年上升趋势,芬太尼透皮贴剂(4.2 mg)和芬太尼透皮贴剂(8.4 mg)的DDDs呈逐年下降趋势;2016年底因取消了药品加成,所有药品的DDC值均出现了下降;多数药物的B/A值均接近1.0,只有盐酸羟考酮缓释片(40 mg)的B/A值连续3年明显小于1.0,芬太尼透皮贴剂(8.4 mg)和氨酚羟考酮片的B/A值连续3年明显大于1.0。结论:该院2014-2016年阿片类镇痛药的品种规格较齐全,使用情况基本合理;可进一步细化监管工作,促进该类药物的规范使用。
[Abstract]:Objective: to investigate the use of opioid analgesics in a hospital and to provide reference for the rational use of opioid drugs.Methods: the sales amount of opioid analgesics, DDDsI, daily average cost (DDC) and ranking ratio (B / A) of opioid analgesics from 2014 to 2016 in our hospital were retrospectively analyzed and compared.Results: the annual sales of opioid analgesics in the hospital increased slightly in 2015 and decreased significantly in 2016. The DDDs of fentanyl transdermal patch, aminophenol hydroxycodone tablet and remifentanil hydrochloride for injection was consistently in the top three.DDDs of fentanyl citrate injection and morphine sulfate sustained-release tablets increased year by year, DDDs of fentanyl transdermal patch and fentanyl transdermal patch decreased year by year.The B / A value of most drugs was close to 1.0, only the B / A value of hydroxycodone hydrochloride sustained release tablets was significantly lower than 1.0 for 3 consecutive years, the B / A value of fentanyl transdermal patch was 8.4 mg) and the B / A value of paracetamol hydroxycodone tablets was significantly higher than 1.0 for 3 consecutive years.Conclusion: the varieties and specifications of opioid analgesics in the hospital from 2014 to 2016 are complete and the usage is basically reasonable, which can further refine the supervision work and promote the standardized use of this kind of drugs.
【作者单位】：中山市人民医院药学部;
【分类号】：R95

【相似文献】